Skip to main content
Erschienen in: Inflammopharmacology 1/2017

07.12.2016 | Original Article

Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial

verfasst von: Yunes Panahi, Nahid Khalili, Ebrahim Sahebi, Soha Namazi, Maryam Saberi Karimian, Muhammed Majeed, Amirhossein Sahebkar

Erschienen in: Inflammopharmacology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Oxidative stress has a key role in the pathogenesis of type II diabetes mellitus (T2DM) and its vascular complications. Antioxidant therapy has been suggested as a potential approach to blunt T2DM development and progression. The aim of this study was to assess the effects of supplementation with curcuminoids, which are natural polyphenolics from turmeric, on oxidative indices in diabetic individuals.

Methods

In this randomized double-blind placebo-controlled trial, 118 subjects with T2DM were randomized to curcuminoids (1000 mg/day co-administered with piperine 10 mg/day) or matching placebo for a period of 8 weeks. Serum total antioxidant capacity, superoxide dismutase (SOD) activities and malondialdehyde (MDA) concentrations were measured at baseline and after the supplementation period.

Results

Curcuminoids supplementation caused a significant elevation in serum total antioxidant capacity (TAC) (p < 0.001) and SOD activities (p < 0.001), while serum MDA levels were significantly reduced compared with the placebo group (p < 0.001). These results remained statistically significant after adjustment for potential confounders (baseline differences in body mass index and fasting serum insulin).

Conclusion

The present results support an antioxidant effect of curcuminoids supplementation in patients with T2DM, and call for future studies to assess the impact of these antioxidant effects on the occurrence of diabetic complications and cardiovascular endpoints.
Literatur
Zurück zum Zitat Amin F, Bano B (2012) Nitric oxide induced damage and preventive effect of curcumin and quercetin on buffalo brain cystatin Current. Proteomics 9:9–17CrossRef Amin F, Bano B (2012) Nitric oxide induced damage and preventive effect of curcumin and quercetin on buffalo brain cystatin Current. Proteomics 9:9–17CrossRef
Zurück zum Zitat Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimer’s Dis 6:367–377 Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimer’s Dis 6:367–377
Zurück zum Zitat Boaz M et al (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213–1218CrossRefPubMed Boaz M et al (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213–1218CrossRefPubMed
Zurück zum Zitat Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRefPubMed Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRefPubMed
Zurück zum Zitat Derosa G, Maffioli P, Simental-Mendia LE, Bo S, Sahebkar A (2016) Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 111:394–404. doi:10.1016/j.phrs.2016.07.004 CrossRefPubMed Derosa G, Maffioli P, Simental-Mendia LE, Bo S, Sahebkar A (2016) Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 111:394–404. doi:10.​1016/​j.​phrs.​2016.​07.​004 CrossRefPubMed
Zurück zum Zitat DiSilvestro RA, Joseph E, Zhao S, Bomser J (2012a) Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J 11:1CrossRef DiSilvestro RA, Joseph E, Zhao S, Bomser J (2012a) Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J 11:1CrossRef
Zurück zum Zitat Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, Ghayour-Mobarhan M (2015) An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial Chinese journal of integrative medicine 21:332–338. doi:10.1007/s11655-015-2160-z PubMed Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, Ghayour-Mobarhan M (2015) An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial Chinese journal of integrative medicine 21:332–338. doi:10.​1007/​s11655-015-2160-z PubMed
Zurück zum Zitat Hogan P, Dall T, Nikolov P (2003) Economic costs of diabetes in the US in 2002. Diabetes Care 26:917CrossRefPubMed Hogan P, Dall T, Nikolov P (2003) Economic costs of diabetes in the US in 2002. Diabetes Care 26:917CrossRefPubMed
Zurück zum Zitat Huang Y, Cai X, Chen P, Mai W, Tang H, Huang Y, Hu Y (2014) Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med 46:684–692CrossRefPubMed Huang Y, Cai X, Chen P, Mai W, Tang H, Huang Y, Hu Y (2014) Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med 46:684–692CrossRefPubMed
Zurück zum Zitat Lonn E et al (2001) Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103:919–925CrossRefPubMed Lonn E et al (2001) Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103:919–925CrossRefPubMed
Zurück zum Zitat Maheshwari RK, Singh AK, Gaddipati J, Srimal RC (2006) Multiple biological activities of curcumin: a short review. Life Sci 78:2081–2087CrossRefPubMed Maheshwari RK, Singh AK, Gaddipati J, Srimal RC (2006) Multiple biological activities of curcumin: a short review. Life Sci 78:2081–2087CrossRefPubMed
Zurück zum Zitat Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84:407–412CrossRef Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84:407–412CrossRef
Zurück zum Zitat Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA (2013) Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. PTR 27:374–379. doi:10.1002/ptr.4715 PubMed Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA (2013) Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. PTR 27:374–379. doi:10.​1002/​ptr.​4715 PubMed
Zurück zum Zitat Momtazi AA, Sahebkar A (2016) Difluorinated curcumin: a promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des 22:4386–4397CrossRefPubMed Momtazi AA, Sahebkar A (2016) Difluorinated curcumin: a promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des 22:4386–4397CrossRefPubMed
Zurück zum Zitat Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A (2016b) Curcumin as a MicroRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol 171:1–38. doi:10.1007/112_2016_3 PubMed Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A (2016b) Curcumin as a MicroRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol 171:1–38. doi:10.​1007/​112_​2016_​3 PubMed
Zurück zum Zitat Montonen J, Knekt P, Jarvinen R, Reunanen A (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27:362–366CrossRefPubMed Montonen J, Knekt P, Jarvinen R, Reunanen A (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27:362–366CrossRefPubMed
Zurück zum Zitat Na LX, Yan BL, Jiang S, Cui HL, Li Y, Sun CH (2014) Curcuminoids target decreasing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes. BES 27:902–906. doi:10.3967/bes2014.127 PubMed Na LX, Yan BL, Jiang S, Cui HL, Li Y, Sun CH (2014) Curcuminoids target decreasing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes. BES 27:902–906. doi:10.​3967/​bes2014.​127 PubMed
Zurück zum Zitat Palanisamy U, Manaharan T, Teng LL, Radhakrishnan AK, Subramaniam T, Masilamani T (2011) Rambutan rind in the management of hyperglycemia. Food Res Int 44:2278–2282CrossRef Palanisamy U, Manaharan T, Teng LL, Radhakrishnan AK, Subramaniam T, Masilamani T (2011) Rambutan rind in the management of hyperglycemia. Food Res Int 44:2278–2282CrossRef
Zurück zum Zitat Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M (2012a) Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr 108:1272–1279. doi:10.1017/S0007114511006544 CrossRefPubMed Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M (2012a) Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr 108:1272–1279. doi:10.​1017/​S000711451100654​4 CrossRefPubMed
Zurück zum Zitat Panahi Y, Sahebkar A, Parvin S, Saadat A (2012b) A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem 49:580–588. doi:10.1258/acb.2012.012040 CrossRefPubMed Panahi Y, Sahebkar A, Parvin S, Saadat A (2012b) A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem 49:580–588. doi:10.​1258/​acb.​2012.​012040 CrossRefPubMed
Zurück zum Zitat Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A (2014a) Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement Ther Med 22:851–857. doi:10.1016/j.ctim.2014.07.006 CrossRefPubMed Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A (2014a) Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement Ther Med 22:851–857. doi:10.​1016/​j.​ctim.​2014.​07.​006 CrossRefPubMed
Zurück zum Zitat Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A (2014b) Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. PTR 28:1625–1631. doi:10.1002/ptr.5174 PubMed Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A (2014b) Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. PTR 28:1625–1631. doi:10.​1002/​ptr.​5174 PubMed
Zurück zum Zitat Panahi Y, Badeli R, Karami GR, Sahebkar A (2015a) Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. PTR 29:17–21. doi:10.1002/ptr.5211 PubMed Panahi Y, Badeli R, Karami GR, Sahebkar A (2015a) Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. PTR 29:17–21. doi:10.​1002/​ptr.​5211 PubMed
Zurück zum Zitat Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A (2015b) Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial. Drug Res 65:567–573. doi:10.1055/s-0034-1389986 Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A (2015b) Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial. Drug Res 65:567–573. doi:10.​1055/​s-0034-1389986
Zurück zum Zitat Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A (2015c) Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clin Nutr 34:1101–1108. doi:10.1016/j.clnu.2014.12.019 CrossRefPubMed Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A (2015c) Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clin Nutr 34:1101–1108. doi:10.​1016/​j.​clnu.​2014.​12.​019 CrossRefPubMed
Zurück zum Zitat Panahi Y, Ghanei M, Hajhashemi A, Sahebkar A (2016b) Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. J Diet Suppl 13:93–105. doi:10.3109/19390211.2014.952865 CrossRefPubMed Panahi Y, Ghanei M, Hajhashemi A, Sahebkar A (2016b) Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. J Diet Suppl 13:93–105. doi:10.​3109/​19390211.​2014.​952865 CrossRefPubMed
Zurück zum Zitat Panahi Y, Hosseini MS, Khalili N, Naimi E, Simental-Mendia LE, Majeed M, Sahebkar A (2016c) Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post hoc analysis of a randomized controlled trial. Biomed Pharmacother Biomedecine Pharmacotherapie 82:578–582. doi:10.1016/j.biopha.2016.05.037 CrossRefPubMed Panahi Y, Hosseini MS, Khalili N, Naimi E, Simental-Mendia LE, Majeed M, Sahebkar A (2016c) Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post hoc analysis of a randomized controlled trial. Biomed Pharmacother Biomedecine Pharmacotherapie 82:578–582. doi:10.​1016/​j.​biopha.​2016.​05.​037 CrossRefPubMed
Zurück zum Zitat Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A (2016d) Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol 68:223–229. doi:10.1097/FJC.0000000000000406 CrossRefPubMed Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A (2016d) Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol 68:223–229. doi:10.​1097/​FJC.​0000000000000406​ CrossRefPubMed
Zurück zum Zitat Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S (1998) Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 30:445–456CrossRefPubMed Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S (1998) Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 30:445–456CrossRefPubMed
Zurück zum Zitat Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 29:351–366CrossRefPubMed Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 29:351–366CrossRefPubMed
Zurück zum Zitat Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A (2016) Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled. PTR 30:1540–1548. doi:10.1002/ptr.5659 PubMed Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A (2016) Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled. PTR 30:1540–1548. doi:10.​1002/​ptr.​5659 PubMed
Zurück zum Zitat Ruby A, Kuttan G, Babu KD, Rajasekharan K, Kuttan R (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83CrossRefPubMed Ruby A, Kuttan G, Babu KD, Rajasekharan K, Kuttan R (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83CrossRefPubMed
Zurück zum Zitat Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A (2003) Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26:3264–3272CrossRefPubMed Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A (2003) Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26:3264–3272CrossRefPubMed
Zurück zum Zitat Sahebkar A (2014a) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. PTR 28:633–642. doi:10.1002/ptr.5045 PubMed Sahebkar A (2014a) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. PTR 28:633–642. doi:10.​1002/​ptr.​5045 PubMed
Zurück zum Zitat Sahebkar A, Henrotin Y (2016) Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 17:1192–1202. doi:10.1093/pm/pnv024 PubMed Sahebkar A, Henrotin Y (2016) Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 17:1192–1202. doi:10.​1093/​pm/​pnv024 PubMed
Zurück zum Zitat Sahebkar A et al (2013) Curcuminoids modulate pro-oxidant–antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res 27:1883–1888CrossRefPubMed Sahebkar A et al (2013) Curcuminoids modulate pro-oxidant–antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res 27:1883–1888CrossRefPubMed
Zurück zum Zitat Sahebkar A, Cicero AF, Simental-Mendia LE, Aggarwal BB, Gupta SC (2016) Curcumin downregulates human tumor necrosis factor-alpha levels: a systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res 107:234–242. doi:10.1016/j.phrs.2016.03.026 CrossRefPubMed Sahebkar A, Cicero AF, Simental-Mendia LE, Aggarwal BB, Gupta SC (2016) Curcumin downregulates human tumor necrosis factor-alpha levels: a systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res 107:234–242. doi:10.​1016/​j.​phrs.​2016.​03.​026 CrossRefPubMed
Zurück zum Zitat Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64:353–356. doi:10.1055/s-2006-957450 CrossRefPubMed Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64:353–356. doi:10.​1055/​s-2006-957450 CrossRefPubMed
Zurück zum Zitat Standl E, Müller M, Schnell O (2009) The impact of glucose-lowering therapy on cardiovascular outcomes. Best Pract Res Clin Endocrinol Metabol 23:401–411CrossRef Standl E, Müller M, Schnell O (2009) The impact of glucose-lowering therapy on cardiovascular outcomes. Best Pract Res Clin Endocrinol Metabol 23:401–411CrossRef
Zurück zum Zitat Uchegbu NN, Ishiwu CN (2016) Germinated Pigeon Pea (Cajanus cajan): a novel diet for lowering oxidative stress and hyperglycemia. Food Sci Nutr Uchegbu NN, Ishiwu CN (2016) Germinated Pigeon Pea (Cajanus cajan): a novel diet for lowering oxidative stress and hyperglycemia. Food Sci Nutr
Zurück zum Zitat Vikramadithyan RK et al (2005) Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Investig 115:2434–2443CrossRefPubMedPubMedCentral Vikramadithyan RK et al (2005) Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Investig 115:2434–2443CrossRefPubMedPubMedCentral
Zurück zum Zitat Zabihi NA, Pirro M, Johnston TP, Sahebkar A (2016) Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des. doi:10.2174/1381612822666161010115235 Zabihi NA, Pirro M, Johnston TP, Sahebkar A (2016) Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des. doi:10.​2174/​1381612822666161​010115235
Zurück zum Zitat Zhou H, Beevers CS, Huang S (2011) The targets of curcumin. Curr Drug Targ 12:332–347CrossRef Zhou H, Beevers CS, Huang S (2011) The targets of curcumin. Curr Drug Targ 12:332–347CrossRef
Metadaten
Titel
Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
verfasst von
Yunes Panahi
Nahid Khalili
Ebrahim Sahebi
Soha Namazi
Maryam Saberi Karimian
Muhammed Majeed
Amirhossein Sahebkar
Publikationsdatum
07.12.2016
Verlag
Springer International Publishing
Erschienen in
Inflammopharmacology / Ausgabe 1/2017
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-016-0301-4

Weitere Artikel der Ausgabe 1/2017

Inflammopharmacology 1/2017 Zur Ausgabe